Dai. Chida, et.al., Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis., Proceedings of the National Academy of Sciences of the United States of America, 2007, 104

http://rdf.ncbi.nlm.nih.gov/pubmed/17989225

Dai. Chida, et.al., Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis., Proceedings of the National Academy of Sciences of the United States of America, 2007, 104

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Mc2r<tm1Dchi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3764974

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal adrenal gland zona fasciculata morphology_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0008294B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• increased spleen weight_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0004952B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• decreased circulating aldosterone level_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0002667B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• postnatal lethality, incomplete penetrance_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0011086B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• abnormal adrenal gland capsule morphology_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0013565B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• decreased heart rate_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0005333B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• decreased circulating adrenaline level_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0005661B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• abnormal glucose homeostasis_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0002078B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• increased circulating chloride level_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0003019B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• increased circulating potassium level_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0005627B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• abnormal gluconeogenesis_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0003383B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• increased circulating adrenocorticotropin level_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0001748B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• decreased circulating corticosterone level_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0002665B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• adrenal gland hypoplasia_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0000640B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• increased thymus weight_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0004955B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• lethargy_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0005202B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• hypoglycemia_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0000189B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi
• decreased total body fat amount_Mc2r<tm1Dchi>/Mc2r<tm1Dchi>
  http://metadb.riken.jp/0010025B6129P2Mc2rtm1DchiMc2rtm1DchiMc2rtm1DchiMc2rtm1Dchi

class

http://purl.org/net/cito/citesAsAuthority

• Mc2r<tm1Dchi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3764974

article

http://www.w3.org/2000/01/rdf-schema#seeAlso

• [Blank]

BRC マウスの系統

http://purl.org/net/cito/citesAsAuthority

• B6;129P2-Mc2r<tm1Dchi>
  http://metadb.riken.jp/db/rikenbrc_mouse/RBRC04911

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating chloride level in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007078
• decreased total body fat amount in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007087
• lethargy in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007082
• decreased circulating adrenaline level in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007085
• decreased circulating aldosterone level in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007077
• abnormal glucose homeostasis in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007075
• decreased circulating corticosterone level in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007076
• abnormal adrenal gland morphology in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014558
• increased circulating adrenocorticotropin level in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007074
• decreased heart rate in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007083
• increased spleen weight in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007080
• postnatal lethality, incomplete penetrance in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007088
• abnormal adrenal gland zona fasciculata morphology in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007086
• adrenal gland hypoplasia in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007073
• hypoglycemia in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007072
• increased thymus weight in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007081
• abnormal adrenal gland capsule morphology in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007089
• increased circulating potassium level in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007084
• abnormal gluconeogenesis in RBRC04911
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1007079

article

http://www.w3.org/2000/01/rdf-schema#seeAlso

• [Blank]